首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nanomedicine

缩写:NANOMEDICINE-UK

ISSN:1743-5889

e-ISSN:1748-6963

IF/分区:4.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3599条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Rajnish Kumar,Nishant R Sinha,Nikhil M Karupathi et al. Rajnish Kumar et al.
Drug delivery in cornea remains a challenge due to its unique dome shape, anatomy, epithelial barrier, rapid drug clearance, and eyelid blinking. Nanoscale-based drug delivery systems are particularly attractive for treating corneal disease...
Angeliki Koimtzidou,Konstantina Chachlioutaki,Dimitrios G Fatouros Angeliki Koimtzidou
Intranasal drug delivery has emerged as an attractive noninvasive route for local, systemic, and central nervous system (CNS) therapy due to its rapid absorption, avoidance of first-pass metabolism, and potential for nose-to-brain transport...
Qing Ji,Huabiao Chen,Xiaochun Sun Qing Ji
Clinical management of inflammatory bowel disease (IBD) is hampered by limited therapeutic targets, primary non-response, secondary loss of efficacy, and safety risks, which undermine clinical outcomes. Probiotics and postbiotics represent ...
Debadatta Mohapatra,Timothy W Corson Debadatta Mohapatra
Conventional therapeutics (eye drops, injectables, ointments, gels) for ocular diseases face several challenges, including low ocular permeability, rapid clearance, low bioavailability, and off-target effects due to complex anatomical barri...
Michael Y T Chow,Jenny K W Lam Michael Y T Chow
Small interfering RNA (siRNA) therapeutics has huge potential for treating many diseases, including those incurable or undruggable by small molecules or antibodies, by harnessing RNA interference (RNAi) to achieve specific silencing of dise...
Muhammad Liaquat Raza,Alam Shah,Habibun Nisa et al. Muhammad Liaquat Raza et al.
Multidrug resistance (MDR) remains a formidable challenge in cancer therapy, often rendering conventional chemotherapeutics ineffective. Recent advances in carbohydrate polymer-based stimuli-responsive nanocarriers have opened new avenues f...
Ye Ri Han,Sang Bong Lee Ye Ri Han
Radiolabeling is a powerful approach for investigating the in vivo behavior of nanomedicine carriers beyond conventional pharmacokinetic analysis. This review examines clinically approved nanocarrier platforms, particularly albumin-bound na...
Qianqian Huang,Fei Luan,Junbo Zou et al. Qianqian Huang et al.
Aims: To investigate whether non‑cytotoxic Au NPs induce reversible structural remodeling of multiple organelles, and to provide a basis for redefining biocompatibility assessment and nanocarrier design. ...
Manon Degey,Stefano Pedergnana,Brigitte Evrard et al. Manon Degey et al.
Surface chemistry affects the in vivo behavior of lipid-based nanocarriers, through lipid-PEGylation (polyethylene glycol, PEG), which forms a steric barrier at the nanoparticle interface and extends systemic circulation. This is relevant f...
Sushanto Kumar Saha,Shukran Alizada,Thomas A Zangle et al. Sushanto Kumar Saha et al.
Aim: Uptake of nanoparticles by macrophages has long been a significant concern for systemically delivered nanoparticle-based therapeutics. While the accumulation of nanoparticles in macrophages reduces the availability o...